Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Apogee Therapeutics Inc. (APGE) had Operating Cash Flow per Share of $-1.89 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-66.10M |
|
-- |
|
-- |
|
$73.17M |
|
$-73.17M |
|
$7.14M |
|
$-66.02M |
|
$-66.02M |
|
$-66.10M |
|
$-66.10M |
|
$-66.10M |
|
$-66.10M |
|
$-73.17M |
|
$-74.53M |
|
58.43M |
|
58.43M |
|
$-1.13 |
|
$-1.13 |
|
| Balance Sheet Financials | |
$516.12M |
|
$6.44M |
|
$141.65M |
|
$657.77M |
|
$31.55M |
|
-- |
|
$6.82M |
|
$38.37M |
|
$619.40M |
|
$619.40M |
|
$619.40M |
|
58.56M |
|
| Cash Flow Statement Financials | |
$-110.51M |
|
$91.11M |
|
$1.80M |
|
$142.08M |
|
$124.49M |
|
$-17.60M |
|
$22.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-115.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.67% |
|
-10.67% |
|
-10.05% |
|
-10.67% |
|
$10.58 |
|
$-1.98 |
|
|
Operating Cash Flow per Share |
$-1.89 |